Primer on Diabetes Management

Symposium on Diabetes and Cancer 2017: Novel Links and Treatments

S. Inzucchi

ACC 2023: SGLT2i Use - Dos and Don'ts

ACC 2023 Conference Coverage

A. Armbruster

ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendat…

ACC 2022 Conference Coverage

P. Heidenreich

Coronary CTA for Assessing CAD - Are We There Yet?

Matthew Budoff

Diabetes Treatment Guidelines Finally Have Entered the 21st Century …

ASPC 2019 Congress on CVD Prevention

R. DeFronzo

Hypertension 2025: New Guidelines and Resistant Hypertension

University of Louisville

K. Ferdinand

Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibiti…

Cardiology Fiesta 2017

R. DeFronzo

SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes

Cardiometabolic Health Congress (CMHC)

L. Sloan

Cholesterol Treatment Decisions: Recent Updates to Guidelines and St…

Gary Martin

Heart Failure in Women: 2025 Update

Scripps Health

M. Kittleson

SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease

Rita Jermyn

Management of Heart Failure

Obafemi Awolowo University

O. A. Akinyele

Anti-Obesity Medications

Michigan Medicine

D. H. Griauzde

The Best of AHA23 for the Primary Care Doctor

Cecilia Bahit

Heart Failure Case Presentations

San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians

B. Greenberg, G. Fonarow, N. Wettersten, M. Rosa Costanzo

Beyond 10-Year Risk: New Paradigms for Long-Term Risk Estimation Wit…

Heart in Diabetes (HiD)

S. Khan

Chest Pain in Emergency Department Settings

University Hospitals

G. Rao, R. Hughes

The Role of SGLT-2 Inhibitors and GLP-1 Receptor Agonists in Pediatr…

ISPAD's 50th Annual Conference 2024

A. Sanghavi

An Efficient Approach to Addressing Syncope in the Office

Dr. Vu Kiet Tran

V. Tran